THORACIC NEOPLASMS

This study is testing whether a drug called tarlatamab can help keep limited-stage small cell lung cancer from getting worse after initial treatment. It will enroll 37 patients who have already completed a specific type of chemo-radiotherapy but were not eligible for a more inten…

This study is testing whether the drug teniposide can help control advanced small cell lung cancer that has worsened despite standard chemotherapy. It is for patients whose cancer has a specific genetic feature called 'c-Myc-driven.' The main goal is to see if the drug shrinks tu…

This study is testing if a special diet containing medium-chain triglycerides (MCTs) can help patients recover faster after lung surgery. Researchers will give the MCT diet to some patients after their operation to see if it reduces fluid buildup and shortens their hospital stay …

This study is testing if using a blood test (ctDNA) to guide treatment decisions helps people with advanced lung cancer live longer. All 63 participants will first receive an immunotherapy drug (cemiplimab). After two cycles, doctors will check the blood test results and the pati…

This study is testing if a drug called mecapegfilgrastim can safely prevent a serious side effect of combined chemotherapy and radiation for chest cancers. The side effect, called myelosuppression, causes dangerously low white blood cell counts, increasing infection risk. Researc…

This study is observing how well a robotic system works in real hospitals to help doctors locate and take samples from suspicious spots in the lungs. It will follow 3,000 patients who are already scheduled to have this robotic-assisted biopsy procedure. The main goal is to see ho…

This study is testing if a specific type of nerve block, called an erector spinae block, can help reduce pain and the need for strong opioid painkillers after lung surgery. It involves 70 adults having lung surgery, often for cancer. The goal is to see if this block, which is saf…